Lupin has received tentative approval from the Food and Drug Administration for darunavir, cobicistat, emtricitabine, and ...
Ramesh Swaminathan, Global CFO of pharmaceutical company Lupin, warns that Trump tariffs could deny many in the U.S. access ...
Stocks like GR Infraprojects,Anant Raj, Aarti Industries, Gujarat Gas, MOIL, Coal India, Indian Bank, Quess Corp, and HM Electro Mech will be in focus on February 3.
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...
17:22 EST ARS Pharmaceuticals (SPRY) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See ...
Guggenheim analyst Vamil Divan initiated coverage of Eledon Pharmaceuticals (ELDN) with a Buy rating and $9 price target Published first on TheFly – the ultimate source for real-time ...
"The tentative approval from the USFDA for our Abacavir, Dolutegravir and Lamivudine Tablets enables us to improve the well-being of pediatric patients with HIV-1, thereby significantly boosting our ...
The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and Valsartan ... a non-exclusive patent licence agreement with Takeda ...
Recursion Pharmaceuticals has a flashy drug development platform. It has a lot to prove about whether that platform's use of AI is helpful. Some power players have backed it with significant ...
HOUSTON and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with ...
WEST LAFAYETTE, Ind. — Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results